U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 19.85% 35.78% 33.39% 44.44% 54.24%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -0.27% 66.30% 199.45% 598.90% --
Total Other Non-Cash Items -15.80% -50.47% -50.52% -65.45% -80.44%
Change in Net Operating Assets -118.72% -91.86% -92.11% -48.29% 268.47%
Cash from Operations -5.02% -29.02% -33.45% -18.08% -56.42%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 43.27% 71.35% 500.94% 427.70% 199.74%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 5,614.29% -100.00% -- -- 200.00%
Cash from Financing 178.91% 17.41% 162.07% 137.55% -55.43%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 191.10% -169.46% 96.27% 98.06% -185.45%
Weiss Ratings